Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,114.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.179%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,114.00
HSX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Return of Capital following EGM

25 Mar 2015 15:29

RNS Number : 4646I
Hiscox Ltd
25 March 2015
 

Announcement for 25 March 2015 post EGM

 

Proposed Return of Capital to Shareholders

 

Hamilton, Bermuda (25 March 2015) - Further to the announcements on 2 March 2015 Hiscox Ltd ("Hiscox" or the "Company") is pleased to announce the results of the Extraordinary General Meeting ("EGM") held earlier today and the consequential approval of the Return of Capital to Shareholders.

 

Result of Extraordinary General Meeting

 

All of the resolutions set out in the Notice of EGM set out in the Circular to Shareholders dated 3 March 2015 (the "Circular") were duly passed on a show of hands at the meeting held at 1.00 p.m. (Guernsey time) earlier today. At the EGM an amendment to resolution 1 was passed to increase the amount of authority for the issue of the E and F Shares from £32,000 to £32,100 in paying up in full up to 321,000,000 E or F Shares. The increase was made to reflect the number of pre existing share awards and share options exercised between the date of the Circular and the EGM. This resolution was then passed as amended. Shareholders have accordingly approved the proposed Return of Capital by way of a special distribution to Shareholders of 45 pence per ordinary share and a further amount of 15 pence per ordinary share, instead of the payment of a final dividend for the financial year ended 31 December 2014.

 

As a result of the passing of the resolutions at the EGM the Company will issue to Shareholders on the register at 4.30 p.m. on 25 March 2015 either one E share of par value 0.01 pence in the capital of the Company ("E Share") or one F share of par value 0.01 in the capital of the Company ("F Share") per Existing Ordinary Share and the 88 for 100 Share Capital Consolidation will be implemented with respect to Shareholders. Further details of the resolutions are set out in the Circular.

 

In accordance with Listing Rule 9.6.2R copies of all resolutions passed at the EGM have been submitted to the National Storage Mechanism and will shortly be available to view at www.hemscott.com/nsm.do.

 

Details of the proxy votes lodged in favour of the Chairman are set out below:

 

Resolution

For

%

Against

%

Withheld

 

 

 

 

 

 

1. To approve the Return of Capital as described in the Circular including the approval of the Option Agreement

254,000,348

99.97

75,599

0.03

490,268

2. To authorise the Directors to allot Ordinary Shares

246,218,750

96.91

7,857,900

3.09

490,268

3. To disapply pre-emption rights

 

253,540,190

99.79

536,460

0.21

490,268

4. To authorise the Company to make market purchases of Ordinary Shares

253,950,453

99.97

75,405

0.03

540,696

 

Results of Return of Capital

 

The Directors have determined to extend the Election Deadline from 1.00 p.m. on 25 March 2015 to 4.30 p.m. on 26 March 2015. Further details as to the results of the Return of Capital including the number of E Shares and F Shares issued to Shareholders as a consequence of the passing of the resolutions at the EGM and the elections from Shareholders received by that Election Deadline will be announced by the Company as soon as possible thereafter.

 

Further details of the Return of Capital are contained in the Circular. Terms used in this announcement have the same meaning as set out in the Circular.

 

 

 

For further information:

Hiscox Ltd

Jeremy Pinchin, Group Company Secretary +1 441 278 8300

Kylie O'Connor, Head of Group Communications, London +44 (0)20 7448 6656

 

This announcement does not constitute, or form part of, an offer to sell or the solicitation of an offer to subscribe for or buy any securities, nor the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issue or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law.

 

The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe such restrictions.

 

No application will be made to the UK Listing Authority or to the London Stock Exchange for any of the E Shares, F Shares, E Deferred Shares or Deferred Shares to be admitted to the Official List or to trading on the London Stock Exchange's main market for listed securities, nor will the E Shares, F Shares, E Deferred Shares or Deferred Shares be admitted to trading on any other recognised investment exchange.

 

None of the E Shares, F Shares, E Deferred Shares, Deferred Shares or New Ordinary Shares have been or will be registered under the United States Securities Act of 1933 as amended (the "US Securities Act") or the state securities laws of the United States and none of them may be offered or sold in the United States unless pursuant to a transaction that has been registered under the US Securities Act and the relevant state securities laws or that is not subject to the registration requirements of the US Securities Act or such laws, either due to an exemption therefrom or otherwise.

 

None of the E Shares, F Shares, E Deferred Shares, Deferred Shares, New Ordinary Shares or this announcement or the Circular has been approved, disapproved or otherwise recommended by any US federal or state securities commission, including the U.S. Securities and Exchange Commission, or other regulatory authority or any non-US securities commission or regulatory authority, nor have such authorities confirmed the accuracy or determined the adequacy of this announcement or the Circular. Any representation to the contrary is a criminal offence in the United States.

 

UBS Limited is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom and acting as financial adviser and corporate broker exclusively for the Company and for no one else in connection with the matters referred to in this announcement or the Circular and will not be responsible to anyone other than the Company (whether or not a recipient of this announcement or the Circular) for providing the protections afforded to clients of UBS Limited nor for providing advice in relation to the matters referred to in this announcement or the Circular or any other matter referred to in this announcement or the Circular. Persons other than the Company are recommended to seek their own financial and professional advice.

 

Apart from the responsibilities and liabilities, if any, which may be imposed on UBS Limited by the Financial Services and Markets Act 2000 (as amended) or the regulatory regime established thereunder, UBS Limited accepts no responsibility or liability, whether arising in tort, contract or otherwise, to Shareholders for the contents of this announcement or the Circular or for any other statement made in connection with the Company, the proposed Return of Capital or the Resolutions. 

 

This announcement has been issued by, and is the sole responsibility of, the Company.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
REGUVRVRVVAOUAR
Date   Source Headline
1st Jun 20201:27 pmRNSTotal Voting Rights
1st Jun 20207:35 amRNSHiscox Ltd response to FCA announcement
28th May 20203:23 pmRNSTR-1: Standard form-notification of major holdings
20th May 20204:21 pmRNSTR-1: Standard form-notification of major holdings
20th May 202012:03 pmRNSDirector / PDMR Shareholding
19th May 202012:09 pmRNSDirector Declaration
18th May 20202:58 pmRNSTR-1: Standard form-notification of major holdings
15th May 20207:00 amRNSAGM Results
14th May 20202:06 pmRNSDirector/PDMR Shareholding
13th May 20204:20 pmRNSTR-1: Standard form-notification of major holdings
13th May 20208:53 amRNSTR-1: Standard form-notification of major holdings
11th May 20202:40 pmRNSTR-1: Standard form-notification of major holdings
6th May 20205:30 pmRNSHiscox
6th May 20207:00 amRNSResults of capital raise
5th May 20204:35 pmRNSProposed capital raise of ordinary shares
5th May 20204:35 pmRNSHiscox Ltd trading statement
4th May 20207:00 amRNSSyndicates 33 and 6104 – results and estimates
1st May 202012:29 pmRNSTotal Voting Rights
29th Apr 20207:00 amRNSResponse to press speculation
22nd Apr 20207:00 amRNSMarket update on COVID-19 exposure
15th Apr 20202:20 pmRNSMarket update re business interruption exposure
14th Apr 20202:38 pmRNSNotice of 2020 Annual General Meeting
8th Apr 20207:00 amRNSUpdate on dividend payment and guidance
1st Apr 202012:07 pmRNSTotal Voting Rights
1st Apr 20207:00 amRNSDirector/PDMR Shareholding
16th Mar 20201:08 pmRNSDirector/PDMR Shareholding
11th Mar 20202:36 pmRNSAnnual Report
5th Mar 20207:00 amRNSDirector/PDMR Shareholding
2nd Mar 20203:38 pmRNSChief Underwriting Officer
2nd Mar 202012:50 pmRNSSyndicates 33 and 6104 – results and estimates
2nd Mar 20207:01 amRNSHiscox Ltd full year results
6th Jan 202010:06 amRNSTR-1: Standard form-notification of major holdings
2nd Jan 20201:13 pmRNSTotal Voting Rights
17th Dec 20192:33 pmRNSNotification of transactions
2nd Dec 20191:15 pmRNSTotal Voting Rights
13th Nov 20197:00 amRNSDirector/PDMR Shareholding
11th Nov 20195:12 pmRNSTR-1: Standard form-notification of major holdings
7th Nov 20192:08 pmRNSHiscox Ltd market announcement
4th Nov 20197:01 amRNSHiscox Ltd Q3 Trading Statement
4th Nov 20197:00 amRNSSyndicates 33 and 6104 - estimates
1st Nov 20193:27 pmRNSTotal Voting Rights
1st Oct 20194:39 pmRNSDirector/PDMR Shareholding
1st Oct 20194:30 pmRNSTotal Voting Rights
20th Sep 20192:35 pmRNSDirector/PDMR Shareholding
18th Sep 20194:18 pmRNS2020 Syndicate Business Forecast
17th Sep 20195:35 pmRNSDirector/PDMR Shareholding
13th Sep 20195:16 pmRNSDirector/PDMR Shareholding
9th Sep 20191:15 pmRNSApplication to be Admitted to Official List
5th Sep 20197:00 amRNSAppointment of Group Chief Underwriting Officer
3rd Sep 20192:40 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.